COMMUNIQUÉS West-GlobeNewswire

Ascent Industries Receives Approval to Continue Operations Under Existing Licensing Following Clark County Hearing
28/06/2019
VANCOUVER, British Columbia, June 28, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. (CSE: ASNT) ("Ascent") announces the successful conclusion of the Clark County Nevada license hearing. The outcome allows the [...]
Managers' transactions
28/06/2019
Company Announcement No. 11/2019 For further information please contact: Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250 Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384 Attachment No 11 [...]
BeiGene Granted Approval to Transition from the Biotech Chapter of the Hong Kong Stock Exchange to a General Listing
28/06/2019
CAMBRIDGE, Mass. and BEIJING, China, June 28, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Akari Therapeutics, Plc Announces $4.5 Million Registered Direct Offering
28/06/2019
NEW YORK and LONDON, June 28, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where [...]
Generex Announces Update on 1:1 Dividend and NASDAQ Listing
28/06/2019
MIRAMAR, Fla., June 28, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) ( http://www.otcmarkets.com/stock/GNBT/quote ) today provided guidance on the previously announced 1:1 [...]
Blissco Announces Q1 2020 Financial Results
28/06/2019
1 st quarter reporting company revenue of $742,285 21 dried flower & pre-rolled Blissco products for sale in select Canadian provinces Subsequent to quarter end, entered into definitive arrangement agreement with [...]
Sorrento Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
28/06/2019
SAN DIEGO, June 28, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical stage, antibody-centric biopharmaceutical company developing new therapies to turn malignant cancers into [...]
Q BioMed Files for Orphan Drug Designation with U.S. FDA for Autism Spectrum Disorder Subtype
28/06/2019
Currently no effective treatment exists for the 20,000 children in the U.S. and 250,000 born worldwide each year with pediatric minimally verbal autism (PMVA) NEW YORK, June 28, 2019 (GLOBE NEWSWIRE) -- Q BioMed Inc. ( [...]
Managers’ transactions
28/06/2019
BioPorto A/S Managers' Transactions June 28, 2019 Company announcement no. 11 Managers’ transactions BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below [...]
Changes in number of shares and votes
28/06/2019
June 28, 2019 Announcement no. 10 Changes in number of shares and votes Completion of share capital increase The Board of Directors of BioPorto A/S (“BioPorto”) decided on June 17, 2019 to partially exercise the [...]
Medexus Pharmaceuticals Schedules Fourth Quarter and Fiscal 2019 Conference Call
28/06/2019
Conference call to be held at 4:30 PM Eastern Time on Monday, July 8, 2019 MONTREAL, June 28, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced [...]
Replimune Reports Fourth Fiscal Quarter and Year 2019 Financial Results and Provides Corporate Update
28/06/2019
RP1: Initiated Phase 2 part of Phase 1/2 clinical trial of RP1 in combination with nivolumab in the U.S. and the U.K. RP1: Initial Data from Phase 1 part of Phase 1/2 clinical trial expected to be presented in the [...]
TCR2 Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes
28/06/2019
CAMBRIDGE, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from [...]
Eve & Co Announces First Shipment of Dried Flower to Newfoundland
28/06/2019
TORONTO, June 28, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQX: EEVVF) is pleased to announce the launch of its cannabis in dried flower format at select [...]
CORRECTING and REPLACING - AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results
28/06/2019
Announces name change to Beyond Air™ Completed uplisting to the NASDAQ and $7.96 million PIPE financing Anticipate PMA submission in the third quarter of calendar 2019 Anticipate CE Mark in the first half of calendar [...]
Novitas Issues Proposed Local Coverage Determination for the 4Kscore® Test
28/06/2019
Proposed LCD will allow Medicare coverage within criteria for the 4Kscore® Test MIAMI, June 28, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a new [...]
Cytokinetics Announces Preclinical Data For Reldesemtiv Presented at the 2019 Annual Cure SMA Conference
28/06/2019
Two Studies Show Addition of Reldesemtiv to SMN-Directed Treatment Increases Muscle Force in Mouse Model of Spinal Muscular Atrophy SOUTH SAN FRANCISCO, Calif., June 28, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, [...]
T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts
28/06/2019
Company ranked #22 on the Boston Business Journal’s annual list of the fastest-growing public companies in Massachusetts LEXINGTON, Mass., June 28, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in [...]
Hemispherx Biopharma CFO Adam Pascale Announces Retirement
28/06/2019
OCALA, Fla., June 28, 2019 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announced today that Adam Pascale is retiring from the position of Chief Financial Officer after nearly a quarter century [...]

Pages